Image
Sylvia K. Plevritis, PhD

Sylvia K. Plevritis, PhD

Professor, Biomedical Data Science
Professor, Radiology
Member, Bio-X
Member, Stanford Cancer Institute
Member, Stanford Cancer Institute
Member, Stanford Cancer Institute
Member, Wu Tsai Neurosciences Institute
M.S., Stanford University, Health Services Research (1996)
PhD, Stanford University, Electrical Engineering (1992)
B.E., The Cooper Union, Electrical Engineering (1985)
Dr. Sylvia K. Plevritis is Professor of Biomedical Data Science, and of Radiology at
Stanford University, and Chair of Biomedical Data Science. She leads a systems
biology cancer research program that bridges genomics, biocomputation, imaging and
population sciences to decipher properties of cancer progression to guide advances in
early detection and treatment response. Dr. Plevritis received her Ph.D. in Electrical
Engineering and M.S. in Health Services Research, both from Stanford University, with
a focus on cancer imaging physics and modeling cancer outcomes, respectively. She
has had a primary authorship role on over 100 scientific cancer-related articles. She is a
fellow of the American Institute for Medical and Biological Engineering (AIMBE) and
Distinguished Investigator in the Academy of Radiology Research. She received
the 2016 Inaugural Award for Basic Scientist of the Year in Stanford Radiology. Dr.
Plevritis has served on numerous NIH study sections, chaired scientific programs for
the several professional societies including the American Association for Cancer
Research (AACR) and presented keynote lectures across multiple scales of
computational cancer biology. Sylvia Plevritis is the Program Director of the Stanford
Center in Cancer Systems Biology (CCSB), Program Director of the Stanford Cancer
Systems Biology Scholars Program (CSBS), and co-Division Chief of Integrative
Biomedical Imaging Informatics at Stanford (IBIIS). In addition, she has been a Principal
Investigator with the NCI Cancer Intervention Surveillance Network (CISNET) for over
fifteen years. She serves on NCI Board of Scientific Advisors, Leadership Council of
the Stanford Cancer Institute and the Leadership Council of the Stanford Bio-X
Program.